Literature DB >> 16181610

Influence of the degree of unsaturation of the acyl side chain upon the interaction of analogues of 1-arachidonoylglycerol with monoacylglycerol lipase and fatty acid amide hydrolase.

Séverine Vandevoorde1, Bijali Saha, Anu Mahadevan, Raj K Razdan, Roger G Pertwee, Billy R Martin, Christopher J Fowler.   

Abstract

Little is known as to the structural requirements of the acyl side chain for interaction of acylglycerols with monoacylglycerol lipase (MAGL), the enzyme chiefly responsible for the metabolism of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the brain. In the present study, a series of twelve analogues of 1-AG (the more stable regioisomer of 2-AG) were investigated with respect to their ability to inhibit the metabolism of 2-oleoylglycerol by cytosolic and membrane-bound MAGL. In addition, the ability of the compounds to inhibit the hydrolysis of anandamide by fatty acid amide hydrolase (FAAH) was investigated. For cytosolic MAGL, compounds with 20 carbon atoms in the acyl chain and 2-5 unsaturated bonds inhibited the hydrolysis of 2-oleoylglycerol with similar potencies (IC50 values in the range 5.1-8.2 microM), whereas the two compounds with a single unsaturated bond were less potent (IC50 values 19 and 21 microM). The fully saturated analogue 1-monoarachidin did not inhibit the enzyme, whereas the lower side chain analogues 1-monopalmitin and 1-monomyristin inhibited the enzyme with IC50 values of 12 and 32 microM, respectively. The 22-carbon chain analogue of 1-AG was also potent (IC50 value 4.5 microM). Introduction of an alpha-methyl group for the C20:4, C20:3, and C22:4 compounds did not affect potency in a consistent manner. For the FAAH and the membrane-bound MAGL, there was no obvious relationship between the degree of unsaturation of the acyl side chain and the ability to inhibit the enzymes. It is concluded that increasing the number of unsaturated bonds on the acyl side chain of 1-AG from 1 to 5 has little effect on the affinity of acylglycerols for cytosolic MAGL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181610     DOI: 10.1016/j.bbrc.2005.09.015

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity.

Authors:  John D Douglass; Yin Xiu Zhou; Amy Wu; John A Zadroga; Angela M Gajda; Atreju I Lackey; Wensheng Lang; Kristen M Chevalier; Steven W Sutton; Sui-Po Zhang; Christopher M Flores; Margery A Connelly; Judith Storch
Journal:  J Lipid Res       Date:  2015-04-04       Impact factor: 5.922

Review 2.  Monoacylglycerol lipase - a target for drug development?

Authors:  C J Fowler
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 3.  Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling.

Authors:  Gernot F Grabner; Robert Zimmermann; Rudolf Schicho; Ulrike Taschler
Journal:  Pharmacol Ther       Date:  2017-02-14       Impact factor: 12.310

4.  Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro.

Authors:  S Vandevoorde; K-O Jonsson; G Labar; E Persson; D M Lambert; C J Fowler
Journal:  Br J Pharmacol       Date:  2006-12-04       Impact factor: 8.739

Review 5.  Lipid-metabolizing serine hydrolases in the mammalian central nervous system: endocannabinoids and beyond.

Authors:  Myungsun Shin; Timothy B Ware; Hyeon-Cheol Lee; Ku-Lung Hsu
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-16       Impact factor: 4.698

6.  Synthesis of phenoxyacyl-ethanolamides and their effects on fatty acid amide hydrolase activity.

Authors:  Lionel Faure; Subbiah Nagarajan; Hyeondo Hwang; Christa L Montgomery; Bibi Rafeiza Khan; George John; Peter Koulen; Elison B Blancaflor; Kent D Chapman
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

Review 7.  The pharmacology of the cannabinoid system--a question of efficacy and selectivity.

Authors:  Christopher J Fowler
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

8.  Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters.

Authors:  JodiAnne T Wood; John S Williams; Lakshmipathi Pandarinathan; Amber Courville; Melissa R Keplinger; David R Janero; Paul Vouros; Alexandros Makriyannis; Carol J Lammi-Keefe
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

9.  Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat.

Authors:  S G Woodhams; A Wong; D A Barrett; A J Bennett; V Chapman; S P H Alexander
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

10.  New Disulfiram Derivatives as MAGL-Selective Inhibitors.

Authors:  Ziad Omran
Journal:  Molecules       Date:  2021-05-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.